The HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: ReutersThe HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: Reuters
The HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: Reuters

Hong Kong to surpass Nasdaq as king of biotech listings in five to 10 years as Chinese scientists dominate field, HKEX chief predicts

  • There is no question HKEX is one of the only two real global biotech equity fundraising centres, CEO Li says
  • Chinese scientists expected to dominate research as they are racing ahead in sector after sector in life sciences

Topic |   Pharmaceuticals
The HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: ReutersThe HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: Reuters
The HKEX has attracted a slew of Chinese-backed biotechnology listings this year. Photo: Reuters
READ FULL ARTICLE